Abstract
Introduction: Large language models (LLMs) are increasingly used in clinical medicine to provide emotional support, deliver cognitive-behavioral therapy, and assist in triage and diagnosis. However, as LLMs are integrated into mental health applications, assessing their inherent personality traits and evaluating their divergence from expected neutrality is essential. This study characterizes the personality profiles exhibited by LLMs using two validated frameworks: the Open Extended Jungian Type Scales (OEJTS) and the Big Five Personality Test. Methods: Four leading LLMs publicly available in 2024 [ChatGPT-3.5 (OpenAI), Gemini Advanced (Google), Claude 3 Opus (Anthropic), and Grok-Regular Mode (X)] were evaluated across both psychometric instruments. A one-way multivariate analysis of variance (MANOVA) was performed to assess inter-model differences in personality profiles. Results: MANOVA demonstrated statistically significant differences across models in typological and dimensional personality traits (Wilks' Lamda = 0.115, p < 0.001). OEJTS results showed ChatGPT-3.5 most often classified as ENTJ and Claude 3 Opus consistently as INTJ, while Gemini Advanced and Grok-Regular leaned toward INFJ. On the Big Five Personality Test, Gemini scored markedly lower on agreeableness and conscientiousness, while Claude scored highest on conscientiousness and emotional stability. Grok-Regular exhibited high openness but more variability in stability. Effect sizes ranged from moderate to large across traits. Conclusion: Distinct personality profiles are consistently expressed across different LLMs, even in unprompted conditions. Given the increasing integration of LLMs into clinical workflows, these findings underscore the need for formal personality evaluation and oversight involving mental health professionals before deployment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos